Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
April 18, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California
April 02, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Agreement with Acupath Laboratories
March 28, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) --
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company...
Interpace Diagnostics Announces Expansion of LabCorp National Agreement
March 20, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments
March 15, 2018 16:01 ET
|
Interpace Diagnostics Group, Inc.
Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for the Full Year, Raising $30 Million in Equity and Significantly Improving Balance Sheet and Cash Position,...
Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call
March 14, 2018 14:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Announces Additional Coverage of Thyroid Tests
March 08, 2018 08:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests
February 26, 2018 08:30 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report
February 22, 2018 13:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics to Present Data on Thyroid, Pancreatic, and Lung Assays
February 12, 2018 09:00 ET
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...